Navigation Links
2 repressor genes identified as essential for placental development
Date:4/16/2012

  • The E2F family of genes is thought to play a crucial role in regulating cell proliferation.
  • It is unclear how these genes carry out their function and interact with one another in intact animals.
  • This study shows that two E2F repressor genes are essential for a functional placenta and for balancing the effect of an E2F activator gene.

COLUMBUS, Ohio Two particular repressor genes in a family of regulatory genes are vital for controlling cell proliferation during development of the placenta, according to a new study by researchers with the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James).

The two genes are called E2f7 and E2f8. Their absence in stem cells results in a placenta made up of overcrowded and poorly organized cells that cannot properly transport oxygen and nutrients or support normal embryonic development.

When placental stem cells were also missing a third gene, the activating gene called E2f3a, the placental defects were corrected and embryos carried to birth.

The findings, published in the journal Developmental Cell, shows at the molecular level how these E2Fs control cell proliferation in intact animals, the researchers say.

"The findings provide insight into the role of these two repressor genes," says principal investigators Gustavo Leone, associate professor of Medicine and associate director of Basic Research.

The two genes belong to a family of regulatory genes that, in humans, has eight members. They are all believed to activate or suppress other genes to control cell division and proliferation in both normal and cancer cells. But which genes they regulate and how they interact with one another in living animals is poorly understood.

"E2F regulatory genes have been thought to be important for a long time, but with so many of them, it's been hard to tell which one is doing what," Leone says.

"Here, we show that the repressors E2f7 and E2f8 are essential for the development of an intact, functional, placenta, and that they balance out the effects of the activating gene E2f3a," Leone says. "Because these two repressors are important for proliferation, they may also play an important role in suppressing tumor development."

For this study, Leone and his colleagues used animal models that lacked one or more of the three E2F genes in trophoblast stem cells, which give rise to the placenta.

Earlier work led by Leone has shown that in some cases, an E2F gene can be an activator in some tissues and a repressor in others.


'/>"/>
Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related medicine news :

1. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
2. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
3. Genes, environment, or chance?
4. UCLA study reveals how genes interact with their environment to cause disease
5. Long-Distance Runners May Have Endurance in Their Genes
6. Genes Behind Tooth Development Discovered
7. Smoking significantly increases risk of aneurysm in people with certain genes
8. Increasing neurogenesis might prevent drug addiction and relapse
9. Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day
10. Cluster of Genes Tied to Alcoholism
11. Cardiogenesis Reports Fourth Quarter and Full-Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... ... Love is in the air at King Kullen! The local grocer is ... staple for Valentine’s Day is a must-have, and can be picked up with all ... are long-stem roses available, but also other flower bouquets, elegantly wrapped and ready to ...
(Date:2/5/2016)... ... 05, 2016 , ... The Muscular Dystrophy Association and Sailormen ... the 14th annual “Appetite for a Cure” campaign on Feb. 1 to raise ... related diseases that severely limit strength and mobility. , Now through March ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... , ... Stuart Bentkover, MD, FACS is thrilled to announce the ... effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts to ... has been approved by the Food and Drug Administration (FDA) as a safe and ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 ... addition of the "Global Musculoskeletal Partnering ... company profile to their offering. ... addition of the "Global Musculoskeletal Partnering ... company profile to their offering. ...
(Date:2/5/2016)... Dehaier Medical Systems Ltd. (Nasdaq: ... develops, markets and sells medical devices and wearable ... and international markets, today announced its corporate ... the Company,s resources to develop its mobile health ... focus more on its major businesses. As of ...
(Date:2/5/2016)... Site Profile: --> ... The Speech Recognition People, announced their latest primary healthcare case study ... reduce turnaround times and to save the practice money. ... 2013 Challenge: --> ,- Wirral CCG ,- ... Six doctors ,- Wirral CCG ,- VoicePower client since 2013 ...
Breaking Medicine Technology: